Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Shock. 2014 Jan;41(1):33–39. doi: 10.1097/SHK.0000000000000067

Figure 3.

Figure 3

Fibrinogen contribution of clot strength between control and TEG-guided prophylaxis groups. There is a trend toward a decreased fibrinogen contribution to clot strength in the TEG-guided prophylaxis group on study days 2 through 4, suggesting that additional LMWH may decrease the fibrinogen contribution to clot strength. The overall difference between groups was not significant using repeated measures ANOVA.